AzTrials
AzTrials

Cigarette AddictionNCT07131891

The Effects of Electronic Cigarette and Traditional Cigarette

An observational study of Cigarette Addiction, run by Atılım University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the study is to investigate and compare the effects of traditional cigarette and e-cigarette consumption habits on sleep quality, fatigue, mental health and quality of life. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Cigarette Addiction
What is being tested?
Fatigue Severity Scale, Depression, Anxiety and Stress Scale-21 and Jenkins Sleep Scale
How many people
533 participants
Where
1 siteTurkey (Türkiye)
Study dates
30 Mar 2025to 1 Aug 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Male and female individuals between the ages of 18-65

Who may be able to join

  • Male and female individuals between the ages of 18-65

Who cannot join

  • -

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Atılım University

    Ankara, Ankara, 06830

Other trials in Turkey (Türkiye)

About this study

Official title: The Effects of Electronic Cigarette and Traditional Cigarette Consumption Habits on Sleep Quality, Fatigue, Mental Health, and Quality of Life

The aim of the study is to investigate and compare the effects of traditional cigarette and e-cigarette consumption habits on sleep quality, fatigue, mental health and quality of life.

Read the detailed description

E-cigarettes are battery-powered devices that vaporize a solution that may or may not contain nicotine. Carcinogens and other toxins in e-cigarettes can have negative effects on physical health, and their potential negative effects on mental health are also a concern. Adults in the US who experience serious psychological distress are reported to be more likely to use traditional cigarettes (tobacco), e-cigarettes, or both than adults without serious psychological distress. A relationship between traditional cigarette smoking and mental illness, including depression, is well-known. Recent studies have also found that depressive symptoms are associated with e-cigarette use. A study comparing the relationship between different cigarette products and depressive symptoms found that dual use (traditional cigarettes and e-cigarettes) in young adults was associated with higher depressive symptoms than single use.

Another mental health factor associated with smoking is sleep health. Nicotine is thought to be the primary mechanism linking traditional cigarette use to sleep disorders, as acute withdrawal during the night can cause uncomfortable and sleep-disrupting physiological symptoms. This relationship is also observed in e-cigarette users. In a study conducted with university students, e-cigarette users reported poorer sleep health compared to non-smokers.

Smoking and e-cigarette use are also known to affect fatigue and quality of life. Cao et al. evaluated non-smokers, traditional cigarette users, e-cigarette users, and dual users in terms of fatigue and quality of life. They reported that non-smokers had the lowest fatigue and highest quality of life among these four groups, while the e-cigarette user group had less fatigue and higher quality of life than the traditional cigarette user group.

Various studies in the literature compare e-cigarette and traditional cigarette users in terms of fatigue, sleep quality, depression, mental health, and quality of life. However, there are insufficient studies evaluating all parameters and investigating the relationships among these parameters. Therefore, we believe that our study will provide valuable contributions to the literature in this area.

Another mental health factor associated with smoking is sleep health. Nicotine is thought to be the mechanism linking traditional cigarette use to sleep disorders, as acute withdrawal during the night can cause uncomfortable and sleep-disrupting physiological symptoms. This relationship is also seen in e-cigarette users. In a study conducted with university students, e-cigarette users reported poorer sleep health compared to non-smokers. Smoking and e-cigarette use are also known to affect fatigue and quality of life. Cao et al. evaluated non-smokers, traditional cigarette users, e-cigarette users, and both in terms of fatigue and quality of life. They reported that non-smokers had the lowest fatigue and highest quality of life among these four groups. The e-cigarette user group had less fatigue and higher quality of life than the traditional cigarette user group. Various studies in the literature compare e-cigarette and traditional cigarette users in terms of fatigue, sleep quality, depression, mental health, and quality of life. However, there are insufficient studies evaluating all parameters and investigating their relationship with each other. Therefore, we believe our study will contribute to the literature in this area.

Being tested
Fatigue Severity Scale, Depression, Anxiety and Stress Scale-21, Jenkins Sleep Scale, Epworth Sleepiness Scale, Short Form-36
Keywords
electronic cigarette, traditional ciagrette, Sleep Quality, Fatigue, Mental Health
Medical subject headings
Vaping, Sleep Initiation and Maintenance Disorders, Fatigue, Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fatigue Severity ScaleOther

    Individuals' fatigue severity will be assessed using the Fatigue Severity Scale (FSS). The scale consists of nine questions, and participants are asked about their fatigue level over the past week. Questions are scored from 1 to 7 using a Likert-type scale, where 1 corresponds to "strongly disagree" and 7 to "strongly agree," with higher scores indicating greater agreement. The total score is calculated by taking the arithmetic mean of all items, with the highest possible score being 7. Scores of 4 and above indicate pathological fatigue. The validity and reliability of the FSS in Turkish have been previously established.

  • Depression, Anxiety and Stress Scale-21Other

    Also called DASS-21

    The 21-item Depression, Anxiety, and Stress Scale (DASS-21) will be administered to assess individuals' levels of depression, anxiety, and stress. The original scale was developed by Lovibond with 42 items. Subsequently, Brown et al. validated a shorter form for the same purpose and created the 21-item DASS-21. The Turkish adaptation of the DASS-21 was conducted by Yılmaz et al. The scale measures three subscales-depression, anxiety, and stress-consisting of seven items each. It is a 4-point Likert-type scale, with 0 indicating "Does not apply to me," 1 "Applies to me somewhat," 2 "Generally applies to me," and 3 "Applies to me completely." All items are scored positively, and each subscale is categorized as normal, mild, moderate, severe, or very severe.

  • Jenkins Sleep ScaleOther

    The Jenkins Sleep Scale consists of four questions that assess sleep problems over a four-week period. Each question is scored from 0 to 5, resulting in a total score ranging from 0 to 20, with higher scores indicating greater sleep disturbances.

  • Epworth Sleepiness ScaleOther

    The Epworth Sleepiness Scale (ESS) was developed to assess daytime sleepiness. It consists of eight items, each scored from 0 to 3, yielding a total score ranging from 0 to 24. Higher scores indicate greater daytime sleepiness. The Turkish version of the scale was validated for reliability and accuracy by İzci et al. in 2008..

  • Short Form-36Other

    Quality of life will be assessed using the Turkish version of the Short Form-36 (SF-36). The SF-36 assesses quality of life under eight subscales: physical functioning, role limitations due to physical health, bodily pain, general health, vitality, social functioning, role limitations due to emotional problems, and mental health. Scores for each subscale are calculated separately, ranging from 0 to 100, with higher scores indicating better health status. A total score is not calculated.

Study groups in NCT07131891
Study groupRoleWhat they receive
Electronic cigaretteElectronic cigarette users
Receives: Other: Fatigue Severity Scale; Other: Depression, Anxiety and Stress Scale-21; Other: Jenkins Sleep Scale; Other: Epworth Sleepiness Scale; Other: Short Form-36
Traditional cigaretteTraditional cigarette users
Receives: Other: Fatigue Severity Scale; Other: Depression, Anxiety and Stress Scale-21; Other: Jenkins Sleep Scale; Other: Epworth Sleepiness Scale; Other: Short Form-36
DualBoth electronic and traditional cigarette users
Receives: Other: Fatigue Severity Scale; Other: Depression, Anxiety and Stress Scale-21; Other: Jenkins Sleep Scale; Other: Epworth Sleepiness Scale; Other: Short Form-36
ControlThose who do not use any tobacco products, whether electronic or traditional
Receives: Other: Fatigue Severity Scale; Other: Depression, Anxiety and Stress Scale-21; Other: Jenkins Sleep Scale; Other: Epworth Sleepiness Scale; Other: Short Form-36

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fatigue Severity Scale

    Individuals' fatigue severity will be assessed using the Fatigue Severity Scale (FSS). The scale consists of 9 questions. Participants are questioned about their level of fatigue over the past week. Questions are scored from 1 to 7. The Likert-type scale is used, with 1 point representing "strongly disagree" and 7 points representing "strongly agree," with higher scores indicating greater agreement. A net score is obtained by calculating the arithmetic mean of all questions. The highest possible score is 7. Scores of 4 and above indicate pathological fatigue. The validity and reliability study of the FSS has been conducted in the Turkish language.

    Measured: From enrollment to the end of the assessment period at 2 hours

  2. Jenkins Sleep Scale

    The Jenkins Sleep Scale consists of four questions that assess sleep problems over a 4-week period. Each question is scored from 0 to 5. The total score ranges from 0 to 20 and indicates increasing sleep disturbance.

    Measured: From enrollment to the end of the assessment period at 2 hours

Secondary outcomes (3)
  1. Depression, Anxiety, and Stress Scale (DASS 21)

    The 21-item "Depression, Anxiety, and Stress Scale (DASS 21)" will be administered to determine individuals' depression, anxiety, and stress levels. The scale was first developed by Lovibond and Lovibond (12) with 42 items. Subsequently, Brown et al. (13) determined that a shorter form was valid enough to perform the same measurement, and the 21-item "Depression, Anxiety, and Stress Scale (DASS 21)" was created. Yılmaz et al. (14) adapted the DASS 21 into Turkish. The scale, which measures depression, stress, and anxiety subscales and consists of 21 questions with 7 items for each subscale, is a 4-point Likert-type scale (0: Does not apply to me, 1: Applies to me somewhat, 2: Generally applies to me, and 3: Applies to me completely). All items on the scale are scored positively, and each subscale is evaluated by classifying it as normal, mild, moderate, severe, and very severe.

    Measured: From enrollment to the end of the assessment period at 2 hours

  2. Epworth Sleepiness Scale

    This scale was developed to assess daytime sleepiness. It consists of a total of eight items, with four different response options ranging from 0 to 3 for each item, and the total score ranges from 0 to 24. The higher the total score, the greater the individual's degree of daytime sleepiness. The scale's validity and reliability in Turkish was conducted by İzci et al. in 2008.

    Measured: From enrollment to the end of the assessment period at 2 hours

  3. Short Form-36

    Quality of life was assessed using the Turkish version of the Short Form 36 (SF-36) (18). The SF-36 assesses quality of life under eight subscales: physical function, physical role difficulty, pain, general health, vitality, social function, emotional role difficulty, and mental health. Scores for each subscale are calculated separately. Subscale scores range from 0 to 100, with higher scores indicating better health. A total score is not calculated.

    Measured: From enrollment to the end of the assessment period at 2 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Aug 2025
  2. Study start30 Mar 2025
  3. Primary completion1 Aug 2025
  4. Study completion1 Aug 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
533 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07131891
Sponsor's protocol ID
6040102411- Cigarette
Status last verified
Aug 2025
First submitted
13 Aug 2025
Last updated
27 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Cigarette Addiction, run by Atılım University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fatigue Severity Scale (time frame: From enrollment to the end of the assessment period at 2 hours). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in